Key facts
- This page summarizes GV 2019 GP, L.L.C.'s Form 4 filing for Verve Therapeutics, Inc. (VERV).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2021, 17:18.
GV 2019 GP, L.L.C. - 21 Jun 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VERV
- Reported as of
- 21 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Jun 2021, 17:18:44 UTC
- Prior SEC filing
- 16 Jun 2021
- Next SEC filing
- 08 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daphne Chang, Authorized Signatory
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
GV 2019 GP, L.L.C. filed Form 4 for Verve Therapeutics, Inc. (VERV) on 22 Jun 2021.
Change
- Previous filing in this sequence was filed on 16 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERV
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +4,029,244
- Change %
- Price
- Shares after
- 4,029,244
- Date
- 21 Jun 2021
- Ownership
- By GV 2019 L.P.
- Footnotes
- F1, F2
VERV
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +443,265
- Change %
- +11%
- Price
- Shares after
- 4,472,509
- Date
- 21 Jun 2021
- Ownership
- By GV 2019 L.P.
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VERV
transaction
Derivative
Series A-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -37,308,792
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- By GV 2019 L.P.
- Underlying class
- Common Stock
- Underlying amount
- 4,029,244
- Exercise price
- Footnotes
- F1, F2
VERV
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -4,104,416
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jun 2021
- Ownership
- By GV 2019 L.P.
- Underlying class
- Common Stock
- Underlying amount
- 443,265
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Series A-2 Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series A-2 Preferred Stock had no expiration date.
Footnote F2
The reported securities are held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2019 GP, L.P., GV 2019 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Footnote F3
The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.